title: Developers seek to finetune toxicity of T-cell therapies.
authors.forename: Chris
authors.initials: C
authors.lastname: Morrison
mesh_terms: D018941:Antigens, CD19 / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000473:pathology; D006801:Humans; D016219:Immunotherapy, Adoptive; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D011948:Receptors, Antigen, T-Cell / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use
chemical_list: D018941:Antigens, CD19; D011948:Receptors, Antigen, T-Cell